MOWOOT (USMIMA S.L.)
Novel, purely physical, non-drug & non-invasive solution to bowel dysfunctions.
Status
IP Type
Patent
Time
12 years
Countries
Coverage
Key Features of ‘Intermittent Colonic Exoperistalsis’ Technology, including apparatus & method (e.g. hardware, treatment patterns, forces, frequency, etc.)
Know more of this patent
Status
IP Type
Patent
Time
12 years
Countries
Coverage
Key Features of ‘Intermittent Colonic Exoperistalsis’ Technology, including apparatus & method (e.g. hardware, treatment patterns, forces, frequency, etc.)
Know more of this patent
Status
IP Type
Patent
Time
12 years
Countries
Coverage
Key Features of ‘Intermittent Colonic Exoperistalsis’ Technology, including apparatus & method (e.g. hardware, treatment patterns, forces, frequency, etc.)
Know more of this patent
Status
IP Type
Patent
Time
12 years
Countries
Coverage
Key Features of ‘Intermittent Colonic Exoperistalsis’ Technology, including apparatus & method (e.g. hardware, treatment patterns, forces, frequency, etc.)
Know more of this patent
Status
IP Type
Patent
Time
–
Countries
Coverage
Advanced Key Features of ‘Intermittent Colonic Exoperistalsis’ Technology, including apparatus & method (e.g. advanced hardware & treatment patterns, forces, frequency, etc.)
Know more of this patent
Status
IP Type
Patent
Time
–
Countries
Coverage
Advanced Key Features of ‘Intermittent Colonic Exoperistalsis’ Technology, including apparatus & method (e.g. advanced hardware & treatment patterns, forces, frequency, etc.)
Know more of this patent
Status
IP Type
Patent
Time
–
Countries
Coverage
Filing Date: May 2023
Key features of pipeline technology, including apparatus & method (e.g. interaction of treatment individualization, digital platform, sensor technology, etc.)
Status
IP Type
Trademark
Time
–
Countries
Coverage
‘Intermittent Colonic Exoperistalis’; ‘I.C.E. Therapy’;
Status
IP Type
Trademark
Time
–
Countries
Coverage
‘Intermittent Colonic Exoperistalis’
Status
IP Type
Trademark
Time
–
Countries
Coverage
‘MOWOOT’
This information is confidential, do not share or copy.
You can visit their website or
Under evaluation at least till: 26th of September 2023
KEEP REVIEWING
